BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22044138)

  • 1. Expression of ABCB5 gene in hematological malignances and its significance.
    Yang M; Li W; Fan D; Yan Y; Zhang X; Zhang Y; Xiong D
    Leuk Lymphoma; 2012 Jun; 53(6):1211-5. PubMed ID: 22044138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study.
    Farawela HM; Khorshied MM; Kassem NM; Kassem HA; Zawam HM
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1323-30. PubMed ID: 24804815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease.
    Rund D; Azar I; Shperling O
    Adv Exp Med Biol; 1999; 457():71-5. PubMed ID: 10500782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy.
    Gruber A; Areström I; Albertioni F; Björkholm M; Peterson C; Vitols S
    Leuk Lymphoma; 1995 Aug; 18(5-6):435-42. PubMed ID: 8528050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
    Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
    Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
    Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
    Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance-associated protein (MRP) in haematological malignancies.
    Nooter K; Burger H; Stoter G
    Leuk Lymphoma; 1996 Feb; 20(5-6):381-7. PubMed ID: 8833393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line.
    Lutz NW; Banerjee P; Wilson BJ; Ma J; Cozzone PJ; Frank MH
    PLoS One; 2016; 11(8):e0161803. PubMed ID: 27560924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDR1/P-GP expression as a prognostic factor in acute leukemias.
    Marie JP; Legrand O
    Adv Exp Med Biol; 1999; 457():1-9. PubMed ID: 10500774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy.
    Chauhan PS; Bhushan B; Singh LC; Mishra AK; Saluja S; Mittal V; Gupta DK; Kapur S
    Exp Mol Pathol; 2012 Feb; 92(1):44-9. PubMed ID: 22037714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen.
    Galimberti S; Nagy B; Benedetti E; Pacini S; Brizzi S; Caracciolo F; Papineschi F; Ciabatti E; Guerrini F; Fazzi R; Canestraro M; Petrini M
    Leuk Lymphoma; 2007 Aug; 48(8):1502-9. PubMed ID: 17701580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperforin inhibits P-gp and BCRP activities in chronic lymphocytic leukaemia cells and myeloid cells.
    Quiney C; Billard C; Faussat AM; Salanoubat C; Kolb JP
    Leuk Lymphoma; 2007 Aug; 48(8):1587-99. PubMed ID: 17701591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).
    van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P
    Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of bcl-2 with P-glycoprotein expression in chronic lymphocytic leukaemia and other haematological neoplasms but of neither marker with ex vivo chemosensitivity or patient survival.
    Bosanquet AG; Bell PB; Burlton AR; Amos TA
    Leuk Lymphoma; 1996 Dec; 24(1-2):141-7. PubMed ID: 9049970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD7 expression in acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
    Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDR1, MRP, topoisomerase IIalpha/beta, and cyclin A gene expression in acute and chronic leukemias.
    Beck J; Niethammer D; Gekeler V
    Leukemia; 1996 Jul; 10 Suppl 3():S39-S45. PubMed ID: 8656699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene expression of breast cancer resistance protein in adult acute lymphocytic leukemia and its clinical significance].
    Jiang XJ; Wang JS; Fang Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):31-4. PubMed ID: 18315895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.
    Schuurhuis GJ; Broxterman HJ; Ossenkoppele GJ; Baak JP; Eekman CA; Kuiper CM; Feller N; van Heijningen TH; Klumper E; Pieters R
    Clin Cancer Res; 1995 Jan; 1(1):81-93. PubMed ID: 9815890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes.
    Lepelley P; Poulain S; Grardel N; Preudhomme C; Cosson A; Fenaux P
    Leuk Lymphoma; 1998 May; 29(5-6):547-51. PubMed ID: 9643568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.